Cargando…
Serum miR-22 may be a biomarker for papillary thyroid cancer
The present study aimed to examine whether serum microRNA (miR)-22 may be considered a potential biomarker to differentiate patients with papillary thyroid cancer (PTC) from healthy controls. Reverse transcription-quantitative polymerase chain reaction demonstrated that serum miR-22 expression was s...
Autores principales: | Wang, Deping, Guo, Changxiu, Kong, Tingting, Mi, Guangxi, Li, Jiantao, Sun, Yuhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396224/ https://www.ncbi.nlm.nih.gov/pubmed/30867770 http://dx.doi.org/10.3892/ol.2019.10011 |
Ejemplares similares
-
Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015) -
Correction: Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma
por: Li, Min, et al.
Publicado: (2015) -
MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer
por: Dai, Lei, et al.
Publicado: (2017) -
Serum biomarkers of papillary thyroid cancer
por: Makki, Fawaz M, et al.
Publicado: (2013) -
miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma
por: Qiu, Zhenwei, et al.
Publicado: (2017)